PGPRX Mutual Fund

PGPRX Mutual Fund

NAV$29.16
See how much of PGPRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$926,345.08
Expense Ratio
1.12%
Dividend Yield (Current)
1.33%
Holdings
727
Inception Date
Jan 21, 2003
Fund Family
Putnam Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
SEC 30-Day Yield
PRO

Performance

YTD+7.32%
1 Year+9.99%
3 Year+15.22%
5 Year+7.94%
10 Year+10.17%

Asset Allocation

Stocks: 58.39%
Bonds: 36.53%
Cash: 4.41%
Other: 0.67%
See how much of PGPRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
AAPLApple, Inc4.64%
PSDTXPutnam Short Term Investment Fund4.59%
MSFTMicrosoft Corp4.49%
NVDANvidia Corp3.59%
GOOGLAlphabet Inc3.30%
Top 10 Concentration: 31.81%Report Date: Jul 31, 2026
Download all 727 holdings for PGPRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.33%
Latest Distribution
$1.71
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PGPRX Mutual Fund Overview

PGPRX Mutual Fund (George Putnam Balanced Fund Class R) is managed by Putnam Investments with $926,345.08 in net assets. PGPRX expense ratio is 1.12%, holding 727 positions across sectors including Financials, Information Technology, Health Care. Inception date: 2003-01-21.

PGPRX performance shows a YTD return of 7.32%. The 1-year return is 9.99% and the 5-year return is 7.94%. PGPRX dividend yield stands at 1.33%.

PGPRX top holdings include Apple, Inc (4.6%), Putnam Short Term Investment Fund (4.6%), Microsoft Corp (4.5%), Nvidia Corp (3.6%), Alphabet Inc (3.3%). Go to all PGPRX holdings, PGPRX sectors, or PGPRX dividends.

PGPRX can be compared against other funds. Use PGPRX overlap to find shared positions, or PGPRX vs another fund for a side-by-side view. PGPRX alternatives are available via the screener, along with tax-loss harvesting opportunities.